BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 11479841)

  • 1. Heparin-binding EGF-like growth factor decreases apoptosis in intestinal epithelial cells in vitro.
    Michalsky MP; Kuhn A; Mehta V; Besner GE
    J Pediatr Surg; 2001 Aug; 36(8):1130-5. PubMed ID: 11479841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proinflammatory cytokines TNF-alpha and IFN-gamma alter laminin expression under an apoptosis-independent mechanism in human intestinal epithelial cells.
    Francoeur C; Escaffit F; Vachon PH; Beaulieu JF
    Am J Physiol Gastrointest Liver Physiol; 2004 Sep; 287(3):G592-8. PubMed ID: 15087281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparin-binding EGF-like growth factor down regulates proinflammatory cytokine-induced nitric oxide and inducible nitric oxide synthase production in intestinal epithelial cells.
    Lara-Marquez ML; Mehta V; Michalsky MP; Fleming JB; Besner GE
    Nitric Oxide; 2002 Mar; 6(2):142-52. PubMed ID: 11890738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparin-binding epidermal growth factor-like growth factor protects rat intestine from ischemia/reperfusion injury.
    Pillai SB; Hinman CE; Luquette MH; Nowicki PT; Besner GE
    J Surg Res; 1999 Dec; 87(2):225-31. PubMed ID: 10600353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bladder epithelial cells from patients with interstitial cystitis produce an inhibitor of heparin-binding epidermal growth factor-like growth factor production.
    Keay S; Kleinberg M; Zhang CO; Hise MK; Warren JW
    J Urol; 2000 Dec; 164(6):2112-8. PubMed ID: 11061938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HB-EGF enhances restitution after intestinal ischemia/reperfusion via PI3K/Akt and MEK/ERK1/2 activation.
    El-Assal ON; Besner GE
    Gastroenterology; 2005 Aug; 129(2):609-25. PubMed ID: 16083716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of heparin-binding EGF-like growth factor and amphiregulin in the epidermal proliferation of psoriasis in cooperation with TNFalpha.
    Yoshida A; Kanno H; Watabe D; Akasaka T; Sawai T
    Arch Dermatol Res; 2008 Jan; 300(1):37-45. PubMed ID: 17960400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative effects of heparin-binding epidermal growth factor-like growth factor on the growth of cultured human uterine leiomyoma cells and myometrial cells.
    Wang J; Ohara N; Takekida S; Xu Q; Maruo T
    Hum Reprod; 2005 Jun; 20(6):1456-65. PubMed ID: 15760954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heparin-binding EGF-like growth factor downregulates expression of adhesion molecules and infiltration of inflammatory cells after intestinal ischemia/reperfusion injury.
    Xia G; Martin AE; Besner GE
    J Pediatr Surg; 2003 Mar; 38(3):434-9. PubMed ID: 12632363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Timing, route, and dose of administration of heparin-binding epidermal growth factor-like growth factor in protection against intestinal ischemia-reperfusion injury.
    Martin AE; Luquette MH; Besner GE
    J Pediatr Surg; 2005 Nov; 40(11):1741-7. PubMed ID: 16291163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-10 protects mouse intestinal epithelial cells from Fas-induced apoptosis via modulating Fas expression and altering caspase-8 and FLIP expression.
    Bharhani MS; Borojevic R; Basak S; Ho E; Zhou P; Croitoru K
    Am J Physiol Gastrointest Liver Physiol; 2006 Nov; 291(5):G820-9. PubMed ID: 17030898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heparin-binding EGF-like growth factor decreases neutrophil-endothelial cell interactions.
    Rocourt DV; Mehta VB; Wu D; Besner GE
    J Surg Res; 2007 Aug; 141(2):262-6. PubMed ID: 17574583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of epidermal growth factor and heparin-binding epidermal growth factor-like growth factor for prevention of experimental necrotizing enterocolitis.
    Dvorak B; Khailova L; Clark JA; Hosseini DM; Arganbright KM; Reynolds CA; Halpern MD
    J Pediatr Gastroenterol Nutr; 2008 Jul; 47(1):11-8. PubMed ID: 18607263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cooperation between heparin-binding EGF-like growth factor and interleukin-6 in promoting the growth of human myeloma cells.
    Wang YD; De Vos J; Jourdan M; Couderc G; Lu ZY; Rossi JF; Klein B
    Oncogene; 2002 Apr; 21(16):2584-92. PubMed ID: 11971193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparin binding epidermal growth factor-like growth factor is a transforming growth factor beta-regulated gene in intestinal epithelial cells.
    Bulus N; Barnard JA
    Biochem Biophys Res Commun; 1999 Nov; 264(3):808-12. PubMed ID: 10544013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon (IFN)-gamma is a main mediator of keratinocyte (HaCaT) apoptosis and contributes to autocrine IFN-gamma and tumour necrosis factor-alpha production.
    Konur A; Schulz U; Eissner G; Andreesen R; Holler E
    Br J Dermatol; 2005 Jun; 152(6):1134-42. PubMed ID: 15948973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heparin-binding EGF-like growth factor (HB-EGF) and necrotizing enterocolitis.
    Feng J; El-Assal ON; Besner GE
    Semin Pediatr Surg; 2005 Aug; 14(3):167-74. PubMed ID: 16084404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implication of TNF-related apoptosis-inducing ligand in inflammatory intestinal epithelial lesions.
    Begue B; Wajant H; Bambou JC; Dubuquoy L; Siegmund D; Beaulieu JF; Canioni D; Berrebi D; Brousse N; Desreumaux P; Schmitz J; Lentze MJ; Goulet O; Cerf-Bensussan N; Ruemmele FM
    Gastroenterology; 2006 Jun; 130(7):1962-74. PubMed ID: 16762619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heparin-binding epidermal growth factor-like growth factor reduces intestinal apoptosis in neonatal rats with necrotizing enterocolitis.
    Feng J; El-Assal ON; Besner GE
    J Pediatr Surg; 2006 Apr; 41(4):742-7; discussion 742-7. PubMed ID: 16567187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in retinal gene expression in proliferative vitreoretinopathy: glial cell expression of HB-EGF.
    Hollborn M; Tenckhoff S; Jahn K; Iandiev I; Biedermann B; Schnurrbusch UE; Limb GA; Reichenbach A; Wolf S; Wiedemann P; Kohen L; Bringmann A
    Mol Vis; 2005 Jun; 11():397-413. PubMed ID: 15988409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.